Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
M. D. Willard's research focuses on the efficacy and safety of novel cancer therapeutics, particularly in the context of Non-Small Cell Lung Cancer (NSCLC). Recent publications investigate the intracranial efficacy of olomorasib, a second-generation KRAS G12C inhibitor, in patients with brain metastases. Further studies examine the combined use of olomorasib with chemotherapy and immunotherapy as a first-line treatment for KRAS G12C-mutant NSCLC, reporting on outcomes from clinical trials such as LOXO-RAS-20001 and SUNRAY-01.
In addition to oncology, Willard's work has touched upon psychosocial factors and electronic cigarette use within the military population. With a career marked by 65 publications and over 2,379 citations, contributing to an h-index of 27, Willard is recognized as a highly cited researcher. The researcher also maintains an active laboratory website, suggesting ongoing research activities.
Metrics
- h-index: 27
- Publications: 65
- Citations: 2,379
Selected Publications
-
Psychosocial Factors and Electronic Cigarette Use in the Military Population (2025)
Collaboration Network
Top Collaborators
- Psychosocial Factors and Electronic Cigarette Use in the Military Population
- Psychosocial Factors and Electronic Cigarette Use in the Military Population
- Psychosocial Factors and Electronic Cigarette Use in the Military Population
- Psychosocial Factors and Electronic Cigarette Use in the Military Population
- Psychosocial Factors and Electronic Cigarette Use in the Military Population
Similar Researchers
Based on overlapping research topics